全膝关节置换术前补充维生素D3:一项随机对照试验
该随机对照试验纳入107例初次全膝关节置换患者,手术当日早晨给予50000国际单位维生素D3(57例)或安慰剂(50例)。结果显示两组在术后3周和6周膝关节协会评分功能分量表改善、计时起立行走测试变化及术后90天内并发症方面均无统计学显著差异。
要点
- 手术当日单次口服50000国际单位维生素D3未改善全膝关节置换术后早期功能评分。
- 维生素D3组与安慰剂组在术后3周和6周KSS功能分量表及TUGT变化均无显著差异。
- 术后90天内并发症安慰剂组4例、维生素D3组5例,两组比较P=1.0。
核心结论
- 手术当日补充50000国际单位维生素D3与安慰剂相比,在术后早期功能KSS、TUGT时间或并发症方面未显示出统计学显著差异。
研究设计与样本
- 随机对照试验,纳入107例接受初次全膝关节置换的患者,随机分为手术当日早晨接受50000国际单位维生素D3组(57例)或安慰剂组(50例)。
- 功效分析确定每组需45例,以检测2011版膝关节协会评分功能分量表6分的最小临床重要差异,假设α为0.05、功效为80%。
- 术前及术后3周、6周测量KSS和计时起立行走测试。
- 证据等级为I级,治疗性研究。
主要发现
- KSS较基线的改善在3周时维生素D3组+4.8分 vs 安慰剂组+3.0分(P=0.6),6周时维生素D3组+14.5分 vs 安慰剂组+12.4分(P=0.5)。
- TUGT较基线的变化在3周时维生素D3组+1.2秒 vs 安慰剂组+0.6秒(P=0.6),6周时维生素D3组-0.3秒 vs 安慰剂组-0.9秒(P=0.6)。
- 术后90天内安慰剂组发生4例并发症,维生素D3组发生5例并发症(P=1.0)。
关键数值与推荐
- 维生素D3给药剂量为50000国际单位,于手术当日早晨单次给予。
- 2011版膝关节协会评分功能分量表的最小临床重要差异设定为6分。
- 术后并发症统计时间窗为术后90天内。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this randomized controlled trial was to determine if a one-time dose of vitamin D3 prior to total knee arthroplasty improves function and patient-reported outcomes, while decreasing complications. METHODS: One hundred seven patients undergoing primary total knee arthroplasty were randomized to receive 50,000 international units vitamin D3 (57 patients) or placebo (50 patients) on the morning of surgery. Power analysis determined 45 patients were required in each cohort to detect a minimal clinically important difference of 6 points in the functional component of the 2011 version of the Knee Society Score (KSS), assuming an alpha of 0.05 and power of 80%. KSS and a Timed Up and Go Test (TUGT) were measured preoperatively and at 3 and 6 weeks postoperatively. RESULTS: There was no difference in improvement of KSS at 3 weeks (+4.8 points vitamin D3 versus +3.0 points placebo; P = .6) or 6 weeks (+14.5 points vitamin D3 versus +12.4 points placebo; P = .5) from baseline. There was no difference in change in TUGT at 3 weeks (+1.2 seconds vitamin D3 versus +0.6 seconds placebo; P = .6) or 6 weeks (-0.3 seconds vitamin D3 versus -0.9 seconds placebo; P = .6) from baseline. There were 4 complications in the placebo cohort within the first 90 days postoperatively and 5 complications in the vitamin D3 cohort (P = 1.0). CONCLUSION: Supplementation with 50,000 international units vitamin D3 on the day of surgery failed to demonstrate statistical significant differences in functional KSS, TUGT times, or complications in the early postoperative period compared to placebo. LEVEL OF EVIDENCE: Level I, therapeutic study.
引用
- Weintraub MT, Guntin J, Yang J, et al. Vitamin D3 Supplementation Prior to Total Knee Arthroplasty: A Randomized Controlled Trial. J Arthroplasty. 2022. PMID: 35988825. doi:10.1016/j.arth.2022.08.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。